Company

Meryx Inc.

Meryx Inc. is a Chapel Hill pharmaceutical company developing prescription medicines for chronic diseases.

About

Founded in 2013 and headquartered in Chapel Hill, US, Meryx Inc. develops prescription medications aimed at chronic diseases and unmet medical needs. In December 2021, Tyrogenex Inc. acquired a majority stake from Eshelman Ventures. Its most recent deal was a USD 2.50 mn venture debt round on 2021-12-07, and the company is at the Series A stage.

2Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in